SynCardia says the FDA approved a clinical trial of its artificial heart as a bridge to transplant for patients with heart failure. SynCardia Systems said today that it won FDA approval for a clinical trial of its artificial heart as

Related posts:

  1. ProChon Biotech closes $4 million bridge loan from existing backers
  2. Mesoblast Limited’s (ASX:MSB) First Patients In Bone Marrow Transplant Trial Show Earlier Engraftment
  3. ReGen Closes Bridge Financing
Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone